Tumor necrosis factor-alpha-converting enzyme controls surface expression of c-Kit and survival of embryonic stem

Anthony C Cruz1, Brendon T Frank, Samuel T Edwards

  • 1Cardiovascular Research Institute, University of California, San Francisco, California 94143, USA.

Insights

Tumor necrosis factor alpha-converting enzyme (TACE) sheds the c-Kit receptor, impacting mast cell survival. This TACE-mediated shedding regulates c-Kit levels and influences mast cell apoptosis.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Immunology

Background:

  • Disintegrins and metalloproteinases (ADAMs) regulate cell signaling through protein hydrolysis.
  • The receptor tyrosine kinase c-Kit (CD117) is crucial for mast cell survival.
  • Elevated serum c-Kit levels in mast cell disorders suggest shedding mechanisms.

Purpose of the Study:

  • To identify the metalloproteinase responsible for c-Kit shedding in mast cells.
  • To investigate the role of TACE (ADAM-17) in c-Kit ectodomain release.
  • To determine how TACE-mediated c-Kit shedding affects mast cell survival.

Main Methods:

  • Stimulation of transfected cells and mast cells with phorbol 12-myristate 13-acetate (PMA).
  • Overexpression and deficiency studies using TACE.
  • Analysis of surface c-Kit expression and apoptosis in wild-type and mutant TACE mast cells.

Main Results:

  • PMA induced c-Kit ectodomain release, enhanced by TACE overexpression.
  • TACE-deficient fibroblasts showed no inducible c-Kit release.
  • PMA decreased surface c-Kit in wild-type TACE mast cells but not in TACE-deficient cells.
  • TACE-deficient mast cells exhibited reduced constitutive shedding and increased basal c-Kit, with diminished apoptosis.

Conclusions:

  • TACE (ADAM-17) is the primary metalloproteinase mediating PMA-induced c-Kit shedding.
  • TACE regulates mast cell survival by controlling c-Kit shedding and surface expression.
  • Targeting TACE may offer therapeutic strategies for mast cell disorders.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Enzyme-linked Receptors01:13

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...